-
公开(公告)号:EP3426732B1
公开(公告)日:2024-07-24
申请号:EP17762344.4
申请日:2017-03-10
IPC分类号: C09D5/08 , C09D163/00 , C07F19/00 , C09D7/60 , C09D7/61
CPC分类号: C07F3/06 , C07F5/003 , C09D5/08 , C09D5/082 , C09D163/00 , C09D7/40 , C09D7/60 , C09D7/61 , C09D7/70 , C08K5/0091
-
公开(公告)号:EP4396175A1
公开(公告)日:2024-07-10
申请号:EP22777908.9
申请日:2022-08-31
IPC分类号: C07D401/12 , A61P31/12 , A61P31/14 , A61K31/454
CPC分类号: C07D401/12 , A61P31/12 , A61P31/14 , C07B2200/1320130101
-
公开(公告)号:EP4354141A3
公开(公告)日:2024-07-10
申请号:EP23211967.7
申请日:2019-12-13
IPC分类号: G01N33/543
CPC分类号: G01N33/54353 , G01N33/54366
摘要: A microfluidic device is provided for conducting multiplex immunoassays to detect multiple target analytes in a liquid sample using a set of tags and anti-tags. The device comprises an array of different anti-tags immobilised on a surface of a sensor for measuring a signal. Each anti-tag is arranged to immobilise a tagged antibody or tagged antigen thereby in use separating tagged immune complexes from the liquid phase affecting the signal measured. The device comprises a sensor chamber for tagged immune complexes to form in the liquid phase and one or more detection zones each comprising the array of different anti-tags for immobilising tagged immune complexes. In use, liquid comprising the tagged immune complexes flows or is fluidically driven from the sensor chamber to the detection zone(s).
-
公开(公告)号:EP4387645A1
公开(公告)日:2024-06-26
申请号:EP22769816.4
申请日:2022-08-18
发明人: JOHNS, Douglas, G. , BANKA, Puja , ZHOU, Zexun , KLAPARA, Artis , TSAY, Fuh-rong , KONG, Jongrock , VARSOLONA, Richard, J. , DESMOND, Richard , MALIGRES, Peter, E. , MAROTA, Melanie , ALLEYNE, Candice , OKOH, Grace, A. , DINUNZIO, James, C. , NOFSINGER, Rebecca , LI, Li , SMITH, Daniel, J. , MAHJOUR, Majid , KOEPLINGER, Kenneth, Alan , XIONG, Yusheng , WUEFLING, Peter W. , HIGGINS, John D.
CPC分类号: A61K38/08 , A61K45/06 , A61P3/06 , A61P9/10 , A61K9/1617 , A61K9/4858 , A61K9/4891 , A61K9/10 , A61K47/10
-
公开(公告)号:EP3372633B1
公开(公告)日:2024-06-26
申请号:EP17187911.7
申请日:2017-08-25
IPC分类号: C08G73/02 , C08F116/38 , C08K5/42 , C08L33/08 , C08L79/02 , C09D133/06 , C09D179/02 , C08L65/00 , B05D1/00 , B05D1/02 , B05D3/14 , C09D133/08 , C09D153/00 , C09D163/00 , C09D165/00 , C09D175/04 , C09D5/24 , C09K3/16
-
公开(公告)号:EP4335512A3
公开(公告)日:2024-06-12
申请号:EP23209010.0
申请日:2018-12-21
申请人: HiberCell, Inc.
发明人: KESICKI, Edward A. , LINDSTRÖM, Johan , PERSSON, Lars Boukharta , VIKLUND, Jenny , FORSBLOM, Rickard , GINMAN, Tobias , HICKEY, Eugene R. , DAHLGREN, Markus K. , GERASYUTO, Aleksey I.
IPC分类号: C07D401/04 , C07D401/10 , C07D401/12 , C07D417/14 , C07D471/04 , C07D491/04 , C07D207/24 , C07D498/04 , C07D498/14 , C07D515/14 , C07D519/00 , C07F5/04 , C07D213/61 , A61K31/405 , A61P35/00
CPC分类号: C07D401/04 , C07D401/10 , C07D401/12 , C07D417/14 , C07D471/04 , C07D491/04 , C07D207/24 , C07D498/04 , C07D498/14 , C07D515/14 , C07D519/00 , C07F5/04 , C07D213/61 , A61P35/00
摘要: The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula:
where A1, A2, G, R1, R2, R3, R4, and W are described herein.-
公开(公告)号:EP4039675B1
公开(公告)日:2024-06-12
申请号:EP21211015.9
申请日:2018-04-11
IPC分类号: C07D213/82 , C07D487/04 , C07D239/28 , A61P35/00
CPC分类号: C07D213/82 , C07D239/28 , C07D487/04 , A61P35/00
-
8.
公开(公告)号:EP4343063A3
公开(公告)日:2024-05-29
申请号:EP24157622.2
申请日:2020-04-16
发明人: TAEGE, Deborah Ann , NASSIRI, Somayeh , ENGLUND, Karl Richard , ZHANG, Kun , LIM, Justin Yune-Te
CPC分类号: E01C7/10 , E01C7/18 , E01C7/262 , E01C11/226 , C04B28/04 , C04B2111/007520130101 , C04B2111/6020130101 , C04B2111/0028420130101 , C04B2111/34320130101 , C04B20/0068 , C04B26/26 , C04B18/022 , C04B2111/0061220130101 , Y02W30/91 , Y02A30/30
摘要: A permeable pavement system (100) including a permeable pavement composition and a related method are provided. The permeable pavement system includes a first layer (102) of a permeable pavement composition including a quantity of a first permeable pavement material (104) and a quantity of cured carbon fiber composite material CCFCM (106) incorporated therewith, the first layer defining a first surface (108); and a second layer (110) of a second permeable pavement material (112) deposited over a substantial entirety of and covering the first surface (108) of the first layer of the permeable pavement composition, wherein the first layer (102) interfaces with the second layer (110) to at least strengthen the permeable pavement system.
-
公开(公告)号:EP4303274A3
公开(公告)日:2024-04-10
申请号:EP23212811.6
申请日:2021-03-05
申请人: The Boeing Company
摘要: Aspects of the present disclosure relate to Schiff base oligomers and uses thereof. In at least one aspect, an oligomer is represented by Formula (IV) wherein each instance of R 9 is independently selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, and ether. Each instance of R 28 and R 29 of Formula (IV) is independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, and aryl. Each instance of R 33 of Formula (IV) is independently selected from the group consisting of alkyl, cycloalkyl, aryl, heterocyclyl, and a bond. Each instance of R 41 of Formula (IV) is independently -NH- or a bond and each instance of R 40 is independently -NH- or -NH-NH-. Each instance of R 42 of Formula (IV) is independently -NH- or a bond and each instance of R 43 is independently -NH- or -NH-NH-.
-
10.
公开(公告)号:EP4343063A2
公开(公告)日:2024-03-27
申请号:EP24157622.2
申请日:2020-04-16
发明人: TAEGE, Deborah Ann , NASSIRI, Somayeh , ENGLUND, Karl Richard , ZHANG, Kun , LIM, Justin Yune-Te
IPC分类号: E01C11/22
摘要: A permeable pavement system (100) including a permeable pavement composition and a related method are provided. The permeable pavement system includes a first layer (102) of a permeable pavement composition including a quantity of a first permeable pavement material (104) and a quantity of cured carbon fiber composite material CCFCM (106) incorporated therewith, the first layer defining a first surface (108); and a second layer (110) of a second permeable pavement material (112) deposited over a substantial entirety of and covering the first surface (108) of the first layer of the permeable pavement composition, wherein the first layer (102) interfaces with the second layer (110) to at least strengthen the permeable pavement system.
-
-
-
-
-
-
-
-
-